These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

205 related items for PubMed ID: 30929860

  • 1. Leveraging Prior Knowledge of Endocrine Immune Regulation in the Therapeutically Relevant Phenotyping of Women With Chronic Fatigue Syndrome.
    Morris MC, Cooney KE, Sedghamiz H, Abreu M, Collado F, Balbin EG, Craddock TJA, Klimas NG, Broderick G, Fletcher MA.
    Clin Ther; 2019 Apr; 41(4):656-674.e4. PubMed ID: 30929860
    [Abstract] [Full Text] [Related]

  • 2. Serum BAFF and APRIL Levels, T-Lymphocyte Subsets, and Immunoglobulins after B-Cell Depletion Using the Monoclonal Anti-CD20 Antibody Rituximab in Myalgic Encephalopathy/Chronic Fatigue Syndrome.
    Lunde S, Kristoffersen EK, Sapkota D, Risa K, Dahl O, Bruland O, Mella O, Fluge Ø.
    PLoS One; 2016 Apr; 11(8):e0161226. PubMed ID: 27536947
    [Abstract] [Full Text] [Related]

  • 3. Hypothalamic-Pituitary-Adrenal Hypofunction in Myalgic Encephalomyelitis (ME)/Chronic Fatigue Syndrome (CFS) as a Consequence of Activated Immune-Inflammatory and Oxidative and Nitrosative Pathways.
    Morris G, Anderson G, Maes M.
    Mol Neurobiol; 2017 Nov; 54(9):6806-6819. PubMed ID: 27766535
    [Abstract] [Full Text] [Related]

  • 4. Effect of disease duration in a randomized Phase III trial of rintatolimod, an immune modulator for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.
    Strayer DR, Young D, Mitchell WM.
    PLoS One; 2020 Nov; 15(10):e0240403. PubMed ID: 33119613
    [Abstract] [Full Text] [Related]

  • 5. A double-blind, placebo-controlled, randomized, clinical trial of the TLR-3 agonist rintatolimod in severe cases of chronic fatigue syndrome.
    Strayer DR, Carter WA, Stouch BC, Stevens SR, Bateman L, Cimoch PJ, Lapp CW, Peterson DL, Chronic Fatigue Syndrome AMP-516 Study Group, Mitchell WM.
    PLoS One; 2012 Nov; 7(3):e31334. PubMed ID: 22431963
    [Abstract] [Full Text] [Related]

  • 6. Efficacy of rintatolimod in the treatment of chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME).
    Mitchell WM.
    Expert Rev Clin Pharmacol; 2016 Jun; 9(6):755-70. PubMed ID: 27045557
    [Abstract] [Full Text] [Related]

  • 7. Cortisol and hypothalamic-pituitary-gonadal axis hormones in follicular-phase women with fibromyalgia and chronic fatigue syndrome and effect of depressive symptoms on these hormones.
    Gur A, Cevik R, Nas K, Colpan L, Sarac S.
    Arthritis Res Ther; 2004 Jun; 6(3):R232-8. PubMed ID: 15142269
    [Abstract] [Full Text] [Related]

  • 8. Stress-induced changes in LPS-induced pro-inflammatory cytokine production in chronic fatigue syndrome.
    Gaab J, Rohleder N, Heitz V, Engert V, Schad T, Schürmeyer TH, Ehlert U.
    Psychoneuroendocrinology; 2005 Feb; 30(2):188-98. PubMed ID: 15471616
    [Abstract] [Full Text] [Related]

  • 9. Treatment of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Systematic Review for a National Institutes of Health Pathways to Prevention Workshop.
    Smith ME, Haney E, McDonagh M, Pappas M, Daeges M, Wasson N, Fu R, Nelson HD.
    Ann Intern Med; 2015 Jun 16; 162(12):841-50. PubMed ID: 26075755
    [Abstract] [Full Text] [Related]

  • 10. Treatment and management of chronic fatigue syndrome/myalgic encephalomyelitis: all roads lead to Rome.
    Castro-Marrero J, Sáez-Francàs N, Santillo D, Alegre J.
    Br J Pharmacol; 2017 Mar 16; 174(5):345-369. PubMed ID: 28052319
    [Abstract] [Full Text] [Related]

  • 11. Rituximab impedes natural killer cell function in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis patients: A pilot in vitro investigation.
    Eaton N, Cabanas H, Balinas C, Klein A, Staines D, Marshall-Gradisnik S.
    BMC Pharmacol Toxicol; 2018 Mar 27; 19(1):12. PubMed ID: 29587879
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Poor sleep quality is associated with greater circulating pro-inflammatory cytokines and severity and frequency of chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) symptoms in women.
    Milrad SF, Hall DL, Jutagir DR, Lattie EG, Ironson GH, Wohlgemuth W, Nunez MV, Garcia L, Czaja SJ, Perdomo DM, Fletcher MA, Klimas N, Antoni MH.
    J Neuroimmunol; 2017 Feb 15; 303():43-50. PubMed ID: 28038892
    [Abstract] [Full Text] [Related]

  • 14. Illness progression in chronic fatigue syndrome: a shifting immune baseline.
    Russell L, Broderick G, Taylor R, Fernandes H, Harvey J, Barnes Z, Smylie A, Collado F, Balbin EG, Katz BZ, Klimas NG, Fletcher MA.
    BMC Immunol; 2016 Mar 10; 17():3. PubMed ID: 26965484
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. A role for homeostatic drive in the perpetuation of complex chronic illness: Gulf War Illness and chronic fatigue syndrome.
    Craddock TJ, Fritsch P, Rice MA, del Rosario RM, Miller DB, Fletcher MA, Klimas NG, Broderick G.
    PLoS One; 2014 Mar 10; 9(1):e84839. PubMed ID: 24416298
    [Abstract] [Full Text] [Related]

  • 19. The role of low-grade inflammation in ME/CFS (Myalgic Encephalomyelitis/Chronic Fatigue Syndrome) - associations with symptoms.
    Jonsjö MA, Olsson GL, Wicksell RK, Alving K, Holmström L, Andreasson A.
    Psychoneuroendocrinology; 2020 Mar 10; 113():104578. PubMed ID: 31901625
    [Abstract] [Full Text] [Related]

  • 20. A comparison of sex-specific immune signatures in Gulf War illness and chronic fatigue syndrome.
    Smylie AL, Broderick G, Fernandes H, Razdan S, Barnes Z, Collado F, Sol C, Fletcher MA, Klimas N.
    BMC Immunol; 2013 Jun 25; 14():29. PubMed ID: 23800166
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.